Health.Zone Web Search

Search results

1. Results from the Health.Zone Content Network

2. Danaher Corporation - Wikipedia

   en.wikipedia.org/wiki/Danaher_Corporation

   History Early years. The company's origins go back to a Massachusetts real estate investment trust organized in 1969 as DMG, Inc. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. DMG had been invested in retirement home developments when it was taken over by the Rales, and in 1984, the company adopted the name Danaher and ...

3. List of largest biomedical companies by market capitalization

   en.wikipedia.org/wiki/List_of_largest_biomedical...

   List of largest biomedical companies by market capitalization. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) with current market capitalization of at least US$10 billion, ranked by their market capitalization. It does not include biotechnology companies that ...

4. Catamaran Corporation - Wikipedia

   en.wikipedia.org/wiki/Catamaran_Corporation

   Catamaran Corporation (formerly SXC Health Solutions) is the former name of a company that now operates within UnitedHealth Group's OptumRX division (since July 2015). It sells pharmacy benefit management and medical record keeping services to businesses in the United States [3] and to a broad client portfolio, including health plans and ...

5. EMCOR (EME) Acquires DMG, Expands in North Texas Market - AOL

   www.aol.com/news/emcor-eme-acquires-dmg-expands...

   For premium support please call: 800-290-4726 more ways to reach us

6. Hikma Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Hikma_Pharmaceuticals

   Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

7. Amgen 'encouraged' by weight-loss drug interim data, shares jump

   www.aol.com/news/amgen-first-quarter-profit-dips...

   May 2, 2024 at 6:20 PM. By Deena Beasley. (Reuters) -Amgen on Thursday said it was very encouraged after completing an interim analysis of its mid-stage study of experimental weight-loss drug ...